Targeted light therapy treats hypopigmented disorders by delivering controlled wavelengths directly to areas of pigment loss, encouraging repigmentation while limiting exposure to surrounding skin. In clinical practice, narrowband UVB and 308 nm excimer systems are used for localized vitiligo, leukoderma, hypopigmented scars, and selected hypopigmented stretch marks. Treatment is usually performed as a series of sessions, with results developing progressively rather than appearing after one procedure.
The central benefit of targeted phototherapy is precision: it concentrates pigment-stimulating energy on the lesion, which can improve repigmentation while reducing unnecessary darkening of normal skin. The response varies substantially by diagnosis, lesion location, skin type, and treatment protocol.
How Targeted Light Treats Pigment Loss
The Role of Narrowband UVB and Excimer Systems
Targeted systems commonly use narrowband UVB, particularly 308 nm excimer laser or monochromatic light sources. These wavelengths are directed onto localized hypopigmented areas rather than treating the entire skin surface.
The therapeutic goal is to stimulate residual melanocytes and promote the return of melanin within the affected skin. In conditions with a localized autoimmune component, phototherapy may also help reduce the inflammatory activity directed against melanocytes.
Why Precise Delivery Matters
The applicator or laser spot is generally confined to the boundary of the hypopigmented lesion. This approach helps concentrate treatment where it is needed and limits unwanted tanning or hyperpigmentation in adjacent normal skin.
Precision is particularly important when treating hypopigmented scars and stretch marks, because the contrast between the lesion and surrounding skin can become more noticeable if the unaffected skin darkens.
What Happens During a Treatment Series
Clinicians typically begin with a conservative dose selected according to the patient’s skin response, the treatment system, and the condition being treated. The dose may then be increased gradually to produce mild, temporary erythema without causing excessive inflammation or blistering.
Sessions are often scheduled approximately twice weekly. A course may involve four to ten or more treatments, depending on the diagnosis and the patient’s response, with maintenance treatments sometimes needed to preserve the result.
Treating Different Hypopigmented Conditions
Vitiligo and Localized Leukoderma
For localized vitiligo and other forms of leukoderma, targeted narrowband UVB or excimer treatment aims to reactivate pigment production within stable areas of depigmentation.
Clinical improvement is usually gradual. The primary reference describes approximately 30% to 40% repigmentation as a potential result after an initial treatment series, while other protocols and patient groups have reported higher rates.
These figures should not be treated as guaranteed outcomes. Repigmentation can be uneven, and areas such as the face may respond differently from regions with less favorable melanocyte activity.
Hypopigmented Surgical or Laser Scars
Targeted 308 nm systems can be used for pigment loss associated with surgical scars or previous ablative resurfacing, including procedures involving CO2 or erbium lasers.
The treatment spot is restricted to the lighter scar or leukodermic area. The objective is to restore closer color uniformity without unnecessarily exposing the surrounding skin.
Hypopigmented Stretch Marks
Hypopigmented stretch marks, or striae alba, may be treated with targeted monochromatic light or excimer systems when the main concern is the color contrast between the striae and adjacent skin.
Some clinical protocols have reported approximately 60% to 75% repigmentation after eight to ten sessions, but these results are protocol- and patient-dependent. Stretch marks are structurally altered dermal tissue, so pigment improvement does not necessarily mean that the texture, width, or depression of the striae will disappear.
Pigment Improvement Versus Texture Improvement
What Phototherapy Can Address
Targeted UV-based systems primarily address color loss. They are most relevant when the visible problem is a sharply defined hypopigmented area caused by vitiligo, leukoderma, a scar, or a hypopigmented stretch mark.
They do not function as general skin resurfacing treatments. Their main clinical endpoint is closer color matching through progressive repigmentation.
What Non-Ablative Lasers and IPL Can Address
Non-ablative technologies, including some mid-infrared diode lasers and broad-spectrum IPL systems, address a different aspect of striae. They deliver controlled thermal energy into the dermis while preserving the epidermal surface.
This process is intended to support dermal remodeling, including changes in collagen, elastin, and skin thickness. These treatments may be more relevant to texture smoothing or the vascular redness of early stretch marks, known as striae rubra, than to established pigment loss alone.
Why the Distinction Matters
A patient may have both a pigment problem and a textural problem. In that situation, a clinician may consider separate or combined approaches, but the expected outcomes should remain clearly defined.
A light-based treatment that improves color should not be presented as a complete correction of stretch marks. Likewise, a remodeling laser that smooths texture may not restore melanin in a sharply depigmented lesion.
Combining Targeted Light With Topical Treatment
Potential Adjunctive Agents
Clinicians may combine targeted phototherapy with topical agents such as calcineurin inhibitors or calcipotriol in selected cases.
These medications can complement phototherapy by modifying local immune activity or influencing epidermal and melanocyte-related cellular processes. The combination is intended to improve the likelihood or speed of repigmentation compared with either approach alone.
How Combination Protocols Are Managed
Combination treatment requires individualized prescribing and monitoring. The clinician must account for the diagnosis, lesion stability, location, prior procedures, skin type, medication tolerance, and the risk of irritation or excessive pigmentation.
The use of an adjunctive topical agent does not remove the need for careful light-dose adjustment. Both components should be introduced and evaluated within a controlled clinical protocol.
Understanding the Trade-offs
Results Are Variable
Repigmentation is not uniform across all conditions. Outcomes depend on the cause of hypopigmentation, whether viable melanocytes remain, the stability of the disorder, the location of the lesion, and the patient’s response to treatment.
Reported percentages should therefore be understood as clinical-study ranges, not promises for an individual patient.
Multiple Sessions Are Usually Necessary
Targeted phototherapy is generally a course-based treatment, not a one-time correction. Several initial sessions may be required before visible improvement develops, and maintenance treatment may be needed when pigment is lost again over time.
Patients should be prepared for a gradual process and periodic reassessment rather than immediate color normalization.
Temporary Erythema Is Expected
Mild, short-lived redness may be intentionally induced because it indicates a biologic response to the treatment dose. Excessive pain, prolonged redness, blistering, or pigment changes outside the treatment area require clinical review and may indicate that the protocol needs adjustment.
Stretch-Mark Texture May Persist
For hypopigmented striae, repigmentation can reduce contrast without fully correcting the underlying dermal changes. Width, laxity, atrophy, and surface irregularity may remain even when the color becomes less conspicuous.
Treatment Requires Professional Supervision
Accurate lesion targeting and dose escalation are central to safety. This is especially important for people with darker skin types or a history of post-inflammatory hyperpigmentation, in whom unintended pigment changes may be more visible or persistent.
Making the Right Choice for Your Goal
The appropriate system depends on whether the primary concern is pigment loss, textural change, vascular redness, or a combination of these problems.
- If your primary focus is repigmenting localized vitiligo or leukoderma: Discuss targeted narrowband UVB or a 308 nm excimer system with a clinician experienced in pigmentary disorders.
- If your primary focus is hypopigmented stretch marks: Use targeted phototherapy when color contrast is the main concern, while recognizing that separate dermal-remodeling treatment may be needed for texture.
- If your primary focus is early red stretch marks: Ask whether a non-ablative laser or IPL approach is more appropriate for vascular and textural features than a pigment-focused UV system.
- If your primary focus is maximizing repigmentation: Discuss whether a supervised combination of targeted light and a suitable topical agent is appropriate for your diagnosis.
- If your primary focus is minimizing adverse pigmentation: Prioritize precise lesion targeting, conservative dose escalation, and follow-up with a qualified clinician.
Targeted light therapy can produce meaningful repigmentation, but the most reliable results come from matching the wavelength and treatment plan to the specific cause and type of hypopigmentation.
Summary Table:
| Condition | Treatment Approach | Expected Outcome | Sessions |
|---|---|---|---|
| Vitiligo / Leukoderma | 308 nm excimer or NB-UVB targeted | 30-40% repigmentation initial series | 4-10+ |
| Hypopigmented surgical/laser scars | Targeted 308 nm | Improved color uniformity | 4-10+ |
| Hypopigmented stretch marks (striae alba) | Targeted monochromatic light or excimer | 60-75% repigmentation | 8-10 |
| Early red stretch marks (striae rubra) | Non-ablative lasers or IPL | Dermal remodeling, reduced redness | Varies |
Ready to integrate targeted phototherapy into your practice? BELIS offers professional-grade 308 nm excimer and narrowband UVB systems designed for clinics and premium salons. Our FDA-cleared devices deliver precise, effective treatment for vitiligo, hypopigmented scars, and stretch marks, helping you achieve superior patient outcomes. Contact our experts today to learn how BELIS can elevate your aesthetic offerings and boost patient satisfaction. Contact us now!
Related Products
- Multifunctional Laser Hair Growth Machine Device for Hair Growth
- Multifunctional Laser Hair Growth Machine Device for Hair Growth
- 12D HIFU Machine Device for Facial HIFU Treatment
- Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments
- 4D 12D HIFU Machine Device for Skin Tightening
People Also Ask
- What is a typical treatment schedule when using a laser hair growth device? Maximize Results with the Proven Protocol
- Why do professional-grade laser hair growth devices integrate LCD displays? Achieve Clinical Precision in Every Session
- How do professional-grade laser stimulation devices contribute to improving hairline morphology? Revitalize Growth & Symmetry
- For which conditions have laser hair growth treatment devices been approved? Targeted Solutions for Androgenic Alopecia
- What primary physiological mechanisms enable low-level light therapy (LLLT) and laser hair growth machines to stimulate hair restoration?
